Page last updated: 2024-08-17

quinoxalines and nitrous oxide

quinoxalines has been researched along with nitrous oxide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, E; Li, S; Quock, RM1
Becker, K; Dodt, HU; Eder, M; Kochs, E; Kurz, J; Rammes, G; Ranft, A; Zieglgänsberger, W1
Chung, E; Ohgami, Y; Quock, LP; Quock, RM; Zhang, Y1

Other Studies

3 other study(ies) available for quinoxalines and nitrous oxide

ArticleYear
Role of cyclic GMP in nitrous-oxide-induced anxiolytic-like behavior in the mouse light-dark exploration test.
    Behavioral neuroscience, 2004, Volume: 118, Issue:3

    Topics: Animals; Anxiety; Behavior, Animal; Cyclic GMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Exploratory Behavior; Male; Mice; Nitrous Oxide; Oxadiazoles; Periodicity; Phosphodiesterase Inhibitors; Purinones; Quinoxalines

2004
Nitrous oxide (N2O) pre- and postsynaptically attenuates NMDA receptor-mediated neurotransmission in the amygdala.
    Neuropharmacology, 2007, Volume: 52, Issue:3

    Topics: Amygdala; Analgesics, Non-Narcotic; Animals; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamates; In Vitro Techniques; Lasers; Male; Mice; Mice, Inbred C57BL; Nitrous Oxide; Oxygen; Patch-Clamp Techniques; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission

2007
Involvement of a NO-cyclic GMP-PKG signaling pathway in nitrous oxide-induced antinociception in mice.
    European journal of pharmacology, 2011, Mar-11, Volume: 654, Issue:3

    Topics: Analgesics; Animals; Benzoates; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Glyburide; Imidazoles; Male; Mice; Naphthyridines; Nitric Oxide; Nitrous Oxide; Oxadiazoles; Pyrimidines; Quinoxalines; Signal Transduction; Thionucleotides

2011